2014-Present – Discovery Fellow in Skin Cancer Biology, University of Dundee, UK 2011-2014 – Lecturer in Cell Signalling, University of East Anglia, UK 2008-2011 – Postdoctoral Researcher, Lund University, Sweden 2006-2008 – Postdoctoral Research Fellow, University of Bath, UK 2002-2006 – PhD in Molecular Virology, University of Nottingham, UK

Webster, C. A., Di Silvo, D., Devarajan, A., Bigini, P., Micotti, E., Giudice, C., Salmona, M., Wheeler, G., Sherwood, V.* & Baldelli Bombelli, F.* (2016) An early developmental vertebrate model to assess nanomaterial safety: Bridging cell-based and mammalian nanoparticle toxicity assessment. Nanomedicine, 11:643-656. (*Joint corresponding authors) Sherwood, V.* & Leigh, I. M. (2016) WNT signalling in cutaneous squamous cell carcinoma: A future treatment strategy? Journal of Investigative Dermatology, 136:1760-1767. (*Corresponding author). Ahire, J., Behray, M., Webster, C., Wang, Q., Sherwood, V., Saengkrit, N., Ruktanonchai, U., Woramongkolchai, N., Chao, Y. (2015) Synthesis of Carbohydrate Capped Silicon Nanoparticles and their Reduced Cytotoxicity, In Vivo Toxicity, and Cellular Uptake. Advanced Healthcare Materials, 4:1877-1886. Sherwood, V.* (2015). WNT signaling: An emerging mediator of cancer cell metabolism? Molecular and Cellular Biology, 35: 2-10. Sherwood, V., Chaurasiya, S., Ekstr?m, E., Guilmain, W., Lui, Q., K?ck, T., Brown, K., Hansson, K., Bergqvist, M., Ponten, F., Jirstr?m, K., James, P., & Andersson, T. (2014) WNT5A-mediated β-Catenin-independent signalling is a novel regulator of cancer cell metabolism. Carcinogenesis, 35:784-794. Baldelli Bombelli, F., Webster, C., Moncrieff, M., & Sherwood, V.* (2014) The scope of nanoparticle therapies for the future of metastatic melanoma treatment. The Lancet Oncology, 15: e22-e32. Brown, K., Yang, P., Salvador, D., Kulikauskas, R., Rucola-Baker, H., Robitaille, A. M., Chien, A. J., Moon, R. T. & Sherwood, V.* (2016) WNT/beta-catenin signalling regulates mitochondrial activity to alter the oncogenic potential of melanoma in a PTEN-dependent manner. Oncogene, In Press. (*Corresponding author).